Kentaro Watanabe

13PUBLICATIONS
34CO-AUTHORS
Molecular targetsGene and molecular therapyImmunology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 15, 2024
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression.

Kentaro Watanabe, Keiji Tasaka, Hideto Ogata

|Nov 02, 2022
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.

Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki

|Apr 12, 2022
Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.

Mitsuteru Hiwatari, Masafumi Seki, Ryosuke Matsuno

|Nov 05, 2020
KMT2A-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization.

Shota Kato, Yasuo Kubota, Masahiro Sekiguchi

|Jul 14, 2020
Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets.

Masahiro Sekiguchi, Masafumi Seki, Tomoko Kawai

|Jun 17, 2020
Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.

Shota Kato, Yasuo Kubota, Kentaro Watanabe

Pageof 3

Frequent Collaborators

7 joint publications

Yasuo Kubota

7 joint publications

Junko Takita

5 joint publications

Masahiro Sekiguchi

5 joint publications

Mitsuteru Hiwatari